William Blair upgraded Korro Bio (KRRO) to Outperform from Market Perform. The firm views the risk/reward as favorable for the OPERA Platform and KRRO-121, notes the analyst, who estimates a risk-adjusted net present value of $48.53 per share.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KRRO:
- Korro Bio management to meet virtually with Cantor Fitzgerald
- First Solar downgraded, Fortinet upgraded: Wall Street’s top analyst calls
- Korro Bio upgraded to Buy from Neutral at H.C. Wainwright
- Korro Bio upgraded to Buy from Neutral at Chardan
- Piper upgrades Korro to Overweight on bullish KRRO-121 view